Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: A role of VEGF and possible treatment for SRN in age-related macular degeneration

Gene Therapy

Volumn 7, Issue 11, 2000, Pages 978-985

  Honda, M ^a   Sakamoto, T ^a   Ishibashi, T ^a   Inomata, H ^a   Ueno, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Age related macular degeneration; Gene therapy; Gene transfection; Subretinal neovascularization

Indexed keywords

BALANCED SALT SOLUTION; FLUORESCEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VIRUS VECTOR; VISUAL PIGMENT;

ADENOVIRUS; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ANGIOGRAPHY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0034125023     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301203     Document Type: Article

References (28)

1. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983; 67: 209-213.
2. Ryan SJ, Stout JT, Dugel PU. Subretinal neovascularization. In: SJ Ryan (ed). The Retina, vol 2. Mosby: St Louis, 1994, pp 1027-1047.
3. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996; 37: 1929-1934.
4. Aiello LP et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl J Med 1994; 331: 1480-1487.
5. Lopez PF et al. Transdifferentiated retinal pigment epithelial cell are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996; 37: 855-868.
6. Ishibashi T et al. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 159-167.
7. Sakamoto T et al. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells. Invest Ophthalmol Vis Sci 1995; 36: 1076-1083.
8. Lopez PF et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996; 37: 855-868.
9. Tobe T, Takahashi K, Ohkuma H, Uyama M. Experimental choroidal neovascularization in the rat. J Jpn Ophthalmol Soc 1994; 98: 837-845.
10. Dobi TE, Puliafito AC, Dwetro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol 1989; 107: 264-269.
11. Frank NR, Das A, Weber ML. A model of subretinal neovascularization in the pigmented rat. Curr Eye Res 1989; 8: 239-247.
12. Ferrara N et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442.
13. Okamoto N et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151: 281-291.
14. Borgström P, Hillan KJ, Sriramarao P, Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 1996; 56: 4032-4039.
15. Shibuya M et al. Possible involvement of VECF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis. Princess Takamatsu Symposia 1994; 24: 162-170.
16. Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dynam 1995; 204: 228-239.
17. Takahashi T, Shibuya M. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 1997; 14: 2079-2089.
18. Aiello LP et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457-10461.
19. Anderson WF. Human gene therapy. Science 1992; 256: 808-813.
20. Ogata N et al. Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization. Curr Eye Res 1996; 15: 1008-1018.
21. Zhang NL, Samadani EE, Frank RN. Mitogenesis and retinal pigment epithelial cell antigen expression in the rat after krypton laser photocoagulation. Invest Ophthalmol Vis Sci 1993; 34: 2412-2424.
22. Takehana Y et al. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest Ophthalmol Vis Sci 1999; 40: 459-466.
23. Guerrin M et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995; 164: 385-394.
24. Ferrara N et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med 1998; 4: 336-340.
25. Sakamoto T et al. Retinal functional change caused by an adenoviral vector-mediated transfection of LacZ gene. Hum Gene Ther 1998; 9: 789-799.
26. Ueno H et al. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscl Thromb Vasc Biol 1995; 15: 2246-2253.
27. Fukushima M, Nakashima Y, Sueishi K. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 1989; 30: 1576-1583.
28. Yoshimura N et al. Photocoagulated human retinal pigment epithelial cells produce an inhibitor of vascular endothelial cell proliferation. Invest Ophthalmol Vis Sci 1995; 36: 1686-1691.